JPH0521B2 - - Google Patents
Info
- Publication number
- JPH0521B2 JPH0521B2 JP62167781A JP16778187A JPH0521B2 JP H0521 B2 JPH0521 B2 JP H0521B2 JP 62167781 A JP62167781 A JP 62167781A JP 16778187 A JP16778187 A JP 16778187A JP H0521 B2 JPH0521 B2 JP H0521B2
- Authority
- JP
- Japan
- Prior art keywords
- rumen
- granules
- substances
- abomasum
- physiologically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000008187 granular material Substances 0.000 claims description 30
- 239000000126 substance Substances 0.000 claims description 29
- 235000001014 amino acid Nutrition 0.000 claims description 18
- 229940024606 amino acid Drugs 0.000 claims description 18
- 241000282849 Ruminantia Species 0.000 claims description 17
- 239000013543 active substance Substances 0.000 claims description 16
- 150000001413 amino acids Chemical class 0.000 claims description 15
- 239000011247 coating layer Substances 0.000 claims description 12
- 239000003674 animal food additive Substances 0.000 claims description 11
- 230000001681 protective effect Effects 0.000 claims description 11
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 10
- 229930182817 methionine Natural products 0.000 claims description 10
- 239000007771 core particle Substances 0.000 claims description 9
- 230000002209 hydrophobic effect Effects 0.000 claims description 8
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 5
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 5
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 5
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 4
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 3
- 235000018417 cysteine Nutrition 0.000 claims description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 3
- 229960003067 cystine Drugs 0.000 claims description 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- 229960001230 asparagine Drugs 0.000 claims description 2
- 235000009582 asparagine Nutrition 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims 1
- 210000004767 rumen Anatomy 0.000 description 31
- 210000003165 abomasum Anatomy 0.000 description 17
- 235000015278 beef Nutrition 0.000 description 15
- 239000003760 tallow Substances 0.000 description 15
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 10
- 238000004090 dissolution Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 8
- 230000002378 acidificating effect Effects 0.000 description 7
- 238000005469 granulation Methods 0.000 description 7
- 230000003179 granulation Effects 0.000 description 7
- 239000000395 magnesium oxide Substances 0.000 description 7
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 7
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- -1 nitrogen-containing polysaccharides Chemical class 0.000 description 7
- 238000000576 coating method Methods 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 230000002688 persistence Effects 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
- 239000004473 Threonine Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229920003043 Cellulose fiber Polymers 0.000 description 2
- 235000019743 Choline chloride Nutrition 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229960003178 choline chloride Drugs 0.000 description 2
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 2
- 239000000347 magnesium hydroxide Substances 0.000 description 2
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- HXCGBBALZREMAS-FJXQXJEOSA-M 3-[[(2r)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoate;2-hydroxyethyl(trimethyl)azanium Chemical compound C[N+](C)(C)CCO.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O HXCGBBALZREMAS-FJXQXJEOSA-M 0.000 description 1
- PBBGSZCBWVPOOL-HDICACEKSA-N 4-[(1r,2s)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol Chemical compound C1([C@H](CC)[C@H](CC)C=2C=CC(O)=CC=2)=CC=C(O)C=C1 PBBGSZCBWVPOOL-HDICACEKSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229950001996 hexestrol Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229960004747 ubidecarenone Drugs 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
- 239000003232 water-soluble binding agent Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
Description
産業上の利用分野
本発明は生理活性物質を含有する反すう動物用
飼料添加物粒剤に関する。
さらに詳しく言えば、本発明は飼料等に混入し
て投与する生理活性物質を、反すう動物の第1胃
(ルーメン)内に存在する微生物の作用から保護
し、第4胃以降で消化吸収されるようにした反す
う動物用飼料添加物粒剤に関する。
牛や羊類のような反すう動物ではルーメン内に
は多数の微生物が生存し、本来高等動物では消化
できないセルロースなどの成分を微生物の働きを
借りることによつて利用している。しかしなが
ら、アミノ酸、蛋白質等の生理活性物質を経口投
与すると、その大部分は微生物により分解されて
生理活性を失なうために有効に利用することがで
きない。
従つて、ルーメンでは溶解させずに、第4胃以
降で溶解吸収させる、いわゆるルーメンバイパス
粒剤は、生理活性物質を反すう動物に有効に働か
すために重要であり、従来、種々の粒剤が開発さ
れ、飼料、栄養剤、動物薬等の分野で利用されて
いる。
従来の技術及びその問題点
反すう動物用のルーメンバイパス粒剤では、第
1胃での微生物による有効成分(生理活性物質)
の分解を防止するために、従来、有効成分を疎水
性に変質化する方法(Dairy Japan 31(5)
1986,p42)、第1胃内では不溶性の牛脂等の保
護物質中に有効成分を分散させるか(特公昭56−
1057号)、油脂等の保護物質をコーテイングする
方法(特開昭58−175449号)等があるが、いずれ
も第4胃以降での消化吸収が充分に行なわれない
欠点を有している。
第4胃以降での消化吸収を改善する対策とし
て、中性域の水溶液(第1胃条件液)に不溶性
で、酸性域の水溶液(第4胃条件液)に可溶性の
無機物(炭酸カルシウム等)を添加する方法(特
開昭60−156350号、同60−168351号)、あるいは
中性条件下で安定で塩酸酸性条件下で崩壊または
溶出する物質(セルロース誘導体、ポリビニル誘
導体、含窒素多糖類、多糖類の金属塩)で粒剤の
表面処理を行なう方法(特開昭60−258112号)が
提案されているが、まだ充分満足すべき粒剤は得
られていないのが実情である。
従つて、この発明の目的は第1胃では溶解しに
くく、第4胃以降で確実に溶解せしめることので
きる新規な反すう動物用飼料添加物粒剤を提供す
ることにある。
問題点を解決するための手段
本発明者等は、反すう動物に投与したい生理活
性物質を主要成分とする核粒子を、特定のアミノ
酸と実質的に水に不溶性の油脂等の保護物質を共
存させ、さらに望ましくは水に不溶性で酸に可溶
性の無機物をも共存させたコート層で被覆した構
造の粒剤が反すう動物用飼料添加物に要求される
性能、つまり第1胃で溶けにくく、第4胃以降で
溶け易い性質を有することを見出し、本発明を完
成した。
すなわち、本発明は生理活性物質を主要成分と
する核粒子を、疎水性アミノ酸の1種または2種
以上の混合物2〜50重量%および保護物質25〜98
重量%、さらに所望により水に不溶性で酸に可溶
性の無機物を含有するコート層で被覆してなる反
すう動物用飼料添加物粒剤である。
発明の構成
生理活性物質
本発明において、粒剤(核粒子)の主要成分を
構成する生理活性物質は反すう動物の栄養源、疾
病の予防または治療のために有用な物質であり、
具体的には下記に示すものが挙げられる。
1 天然アミノ酸及び誘導体:メチオニン、リジ
ン、トリプトフアン、スレオニンその他飼料添
加物として用いるアミノ酸、N−アシル−アミ
ノ酸、ヒドロキシ同族化合物、アミノ酸塩酸
塩、アンモニウム塩、ナトリウム塩等;
2 ビタミン類及び誘導体:ビタミンA、ビタミ
ンAパルミチン酸塩、ビタミンA酢酸塩、β−
カロチン、ビタミンD(D2,D3,D4)、ビタミ
ンE、メナジオン重硫酸ナトリウム、ビタミン
B類(チアミン、塩酸チアミン、リボフラビ
ン、ニコチン酸、ニコチン酸アミド、パントテ
ン酸カルシウム、パントテン酸コリン、塩酸ピ
リドキシン、シアノコバラミン、ビオチン、葉
酸、パラアミノ安息香酸)、ビタミンK、ビタ
ミンQ、ビタミンF、ビタミンC等;
3 酵素類:酸性プロテアーゼ、アミラーゼ、リ
パーゼその他の有効酵素類等;
4 動物薬:テトラサイクリン系,アミノ配糖体
系,マクロライド系抗生物質、その他ポリペプ
タイド系、ポリサツカライド系その他の医薬
品、ネグフオン等の駆虫薬、ピペラジン塩等;
5 ホルモン:エストロジエン、スチルベストロ
ール、ヘキセストロール、チロプロテイン、ゴ
イトロジエン等;
6 蛋白質、炭水化物等の栄養源:
7 有効微生物菌体:乳酸菌、ビフイズス菌、ビ
ール酵母をはじめとする酵母類;
8 各種ミネラル類。
これらの生理活性物質は単独で、あるいは2種
類以上を組合わせて使用される。
核粒子の造粒は、生理活性物質をバインダー
(ワツクス状物質、またはカルボキシメチルセル
ロース(CMC)、ヒドロキシプロピルセルロース
(HPC)等水溶性バインダー水溶液)を用いて、
通常の転動造粒法、押出し造粒法、流動造粒法、
攪拌造粒法等により行なわれる。
保護物質
コート層に使用される保護物質は中性付近の水
に難溶性または不溶性で融点が40〜110℃のもの
であり、下記に例示する物質の中から飼料添加物
として動物に投与しても問題のないもの、および
生理活性物質に対して、変質、反応等を起さない
物質を選択して使用する。
1 硬化した植物性脂肪、又は動物性脂肪のワツ
クス、例えば、牛脂、ライスワツクス、木ロ
ウ、密ロウ、キヤデリラワツクス、カルナウバ
ワツクス、ラノリン等;
2 炭素数14〜22を有する直鎖又は分枝状の飽和
又は不飽和のモノカルボン酸;
3 シヨ糖エステル、グリセリン脂肪酸エステル
(ジ,トリ,モノ)、プロピレングリコール脂肪
酸エステル、ソルビタン脂肪酸エステル等。
これら保護物質の使用量は、コート層中の含有
率として25〜98重量%、好ましくは35〜75重量%
である。25重量%以下では特定アミノ酸等のコー
ト層への付着が不充分となり、第1胃内での耐久
性が良好でなくなる。また、98重量%以上では第
4胃以降での溶出性を制御する成分(特定アミノ
酸、無機物)の含量が少な過ぎて効果を期待でき
ない。
疎水性アミノ酸
アミノ酸は本質的に等電点(PH6付近)で水へ
の溶解性が最低になり、酸性またはアルカリ性領
域で溶解度が増大する。従つて、第1胃条件の中
性域では溶けにくく、第4胃条件の酸性域で溶け
易いという性質を有しているが、そのままでは第
1胃で分解されてしまう。本発明者等は飼料上の
問題がない生体の蛋白質を構成するアミノ酸のう
ち、疎水性のイソロイシン(Ile)、ロイシン
(Leu)、トリプトフアン(Trp)、フエニルアラ
ニン(Phe)、メチオニン(Met)、チロシン
(Tyr)、アスパラギン(Asn)、グルタミン
(Gln)、システイン(Cys)、シスチン(Cys−
Cys)またはヒスチジン(His)を前記の保護物
質と共存させると第1胃では分解されないが、第
4胃以降では確実に溶解され、反すう動物用粒剤
のコート層として適していることを見出した。
前記の疎水性アミノ酸はいずれも好ましいが、
特に好ましいのはメチオニン、チロシン、ロイシ
ン、システイン、シスチンである。
前記の疎水性アミノ酸は、1種または2種以上
の混合物が、コート層中の含有率として2〜50重
量%、好ましくは10〜20重量%使用される。2重
量%以下では第4胃以降の溶出性に難点があり、
また50重量%以上では第1胃での耐久性が不充分
となる。
無機物
コート層には、保護物質およびアミノ酸以外
に、所望により第1胃の中性(PH=6〜8)条件
下では安定であるが、第4胃以降の酸性(PH=3
以下)条件下では崩壊または溶出する無機物質が
所望により用いられる。
無機物としては、酸化マグネシウム、水酸化マ
グネシウム、炭酸マグネシウム、酸化カルシウ
ム、炭酸カルシウム、リン酸水素カルシウム、リ
ン酸カルシウム、ピロリン酸カルシウムの1種ま
たは2種以上の混合物、好ましくは酸化マグネシ
ウム、または酸化マグネシウムを含む混合物が用
いられる。
無機物のコート層中の含有率は0〜70重量%、
好ましくは30〜50重量%である。
コーテイング法
本発明においては、反すう動物用飼料添加物粒
剤のコーテイングは、生理活性物質を主要成分と
する核粒子を通常のコーテイング法により、油脂
をバインダーとしてアミノ酸と所望により無機物
をコートすることによつて行なわれる。
例えば、油脂の融点以上、好ましくは融点+5
℃以上に保持した造粒機を用い、核粒子に油脂を
粉末状で添加するか、または油脂を予め溶融した
状態で、好ましくはスプレー法で添加しつつ同時
に微粉末状のアミノ酸と所望により無機物を添加
することにより行なわれる。
なお、コート層の膜厚は、コート層中のアミノ
酸および無機物の含有率にもよるが、通常、核粒
子の表面が完全に被覆される30μm程度以上あれ
ば充分である。
発明の効果
本発明の反すう動物用飼料添加物粒剤は、生理
活性物質を主要成分とする核粒子を、疎水性アミ
ノ酸と保護物質と所望により中性域では不溶性で
酸性域で溶解性の無機物でコートしてなるもので
あり、第1胃では溶解しにくく、第4胃以降では
確実に溶解するので、生理活性物質を反すう動物
に有効に投与することができる。
実施例
以下、実施例および比較例を挙げて本発明を説
明する。
実施例 1
メチオニン1500g、第3リン酸カルシウム
[Ca3(PO4)2]500g、牛脂400gを攪拌型造粒機に
入れ、ジヤケツト温水によつて品温を70℃として
25分間造粒を行なつた。得られた粒子の12〜32メ
ツシユ700gをコーターに入れ、メチオニン(7μ)
35gと酸化マグネシウム70gを混合したものを熱
溶融した牛脂105gでコーテイングし、本発明の
粒剤を得た。
この粒剤をナイロンバツグに入れ、ルーメンフ
イステル装着牛のルーメンに24時間浸漬後取出し
メチオニンの残存率を分析し、第1胃溶出性を測
定した。また粒剤を経口投与後96時間回収した牛
糞中のメチオニン残存率を分析し、第1胃以降残
存率を測定した。その結果、第1胃溶出性は9.4
%、第1胃以降残存性0%であつた。
実施例 2
リジン1700g、牛脂810gを造粒機に入れ、品温
70℃として40分間造粒した。得られた粒子の12〜
32メツシユ700gをコーターに入れ、チロシン
(20μ)30gを熱溶融した牛脂140gでコーテイング
し、粒剤を得た。この粒剤について実施例1と同
様のテストを行なつたところ、第1胃溶出性は
20.2%第1胃以降残存性は0%であつた。
比較例 1〜3
実施例1において、コーテイングを行なわない
粒剤(比較例1)、実施例2においてコーテイン
グを行なわない粒剤(比較例2)および実施例1
において、牛脂のみでコーテイングを行なつた粒
剤(比較例3)を調製し、各々について実施例1
と同様のテストを行ない下表の結果を得た。
INDUSTRIAL APPLICATION FIELD The present invention relates to ruminant feed additive granules containing physiologically active substances. More specifically, the present invention protects physiologically active substances administered by mixing them into feed etc. from the action of microorganisms present in the rumen of ruminants, and allows them to be digested and absorbed in the abomasum and beyond. The present invention relates to a feed additive granule for ruminants. In ruminant animals such as cows and sheep, many microorganisms live in the rumen, and by borrowing the action of microorganisms, components such as cellulose that cannot be digested by higher animals are utilized. However, when physiologically active substances such as amino acids and proteins are orally administered, most of them are degraded by microorganisms and lose their physiological activity, so they cannot be used effectively. Therefore, so-called rumen bypass granules, which do not dissolve in the rumen but are dissolved and absorbed in the abomasum and beyond, are important for the effective action of physiologically active substances on ruminants, and various granules have been developed in the past. It is used in fields such as feed, nutrients, and veterinary medicine. Conventional technology and its problems In rumen bypass granules for ruminants, active ingredients (physiologically active substances) are removed by microorganisms in the rumen.
In order to prevent the decomposition of active ingredients, conventional methods have been used to make active ingredients hydrophobic (Dairy Japan 31 (5)
1986, p42), or disperse the active ingredient in a protective substance such as beef tallow, which is insoluble in the rumen (Japanese Patent Publication No. 1986-
No. 1057) and a method of coating with a protective substance such as oil (Japanese Patent Application Laid-Open No. 175449/1983), but both have the disadvantage that digestion and absorption in the abomasum and beyond are not sufficiently carried out. As a measure to improve digestion and absorption in the abomasum and beyond, inorganic substances (calcium carbonate, etc.) that are insoluble in aqueous solutions in the neutral range (rumen-conditioned solution) and soluble in aqueous solutions in the acidic range (rumen-conditioned solution) (JP-A-60-156350, JP-A-60-168351), or substances that are stable under neutral conditions and disintegrate or elute under hydrochloric acid acidic conditions (cellulose derivatives, polyvinyl derivatives, nitrogen-containing polysaccharides, A method of surface-treating granules with metal salts of polysaccharides has been proposed (Japanese Patent Application Laid-open No. 258112/1983), but the reality is that fully satisfactory granules have not yet been obtained. Therefore, an object of the present invention is to provide a novel feed additive granule for ruminants that is difficult to dissolve in the rumen and can be reliably dissolved in the abomasum and beyond. Means for Solving the Problems The present inventors prepared core particles whose main component is a physiologically active substance to be administered to ruminants by coexisting a specific amino acid and a protective substance such as a substantially water-insoluble oil or fat. More preferably, granules coated with a coating layer containing water-insoluble and acid-soluble inorganic substances have the properties required for ruminant feed additives, that is, they are difficult to dissolve in the rumen, They discovered that it has a property of being easily dissolved in the stomach and beyond, and completed the present invention. That is, the present invention comprises a core particle containing a physiologically active substance as a main component, 2 to 50% by weight of one or a mixture of two or more hydrophobic amino acids, and 25 to 98% of a protective substance.
This is a feed additive granule for ruminants, which is coated with a coating layer containing a water-insoluble, acid-soluble inorganic substance, if desired. Physiologically Active Substance Constituting the Invention In the present invention, the physiologically active substance constituting the main component of the granules (core particles) is a substance useful as a nutritional source for ruminants and for preventing or treating diseases.
Specifically, the following may be mentioned. 1. Natural amino acids and derivatives: methionine, lysine, tryptophan, threonine, and other amino acids used as feed additives, N-acyl-amino acids, hydroxy homologues, amino acid hydrochlorides, ammonium salts, sodium salts, etc.; 2. Vitamins and derivatives: Vitamin A , vitamin A palmitate, vitamin A acetate, β-
Carotene, vitamin D (D 2 , D 3 , D 4 ), vitamin E, sodium menadione bisulfate, B vitamins (thiamine, thiamine hydrochloride, riboflavin, nicotinic acid, nicotinamide, calcium pantothenate, choline pantothenate, hydrochloric acid) pyridoxine, cyanocobalamin, biotin, folic acid, para-aminobenzoic acid), vitamin K, vitamin Q, vitamin F, vitamin C, etc.; 3. Enzymes: acidic protease, amylase, lipase and other effective enzymes; 4. Veterinary drugs: tetracyclines, Aminoglycosides, macrolide antibiotics, other polypeptides, polysaccharides and other pharmaceuticals, anthelmintic drugs such as Negufuon, piperazine salts, etc.; 5 Hormones: Estrodiene, stilbestrol, hexestrol, thyroprotein , goitolodiene, etc.; 6. Nutrient sources such as proteins and carbohydrates; 7. Effective microbial cells: yeasts including lactic acid bacteria, bifidobacteria, and brewer's yeast; 8. various minerals. These physiologically active substances may be used alone or in combination of two or more. The core particles are granulated by granulating the physiologically active substance using a binder (wax-like substance or an aqueous solution of a water-soluble binder such as carboxymethyl cellulose (CMC) or hydroxypropyl cellulose (HPC)).
Normal rolling granulation method, extrusion granulation method, fluidized granulation method,
This is carried out by a stirring granulation method or the like. Protective substances The protective substances used in the coating layer are poorly soluble or insoluble in near-neutral water and have a melting point of 40 to 110°C, and can be administered to animals as feed additives from among the substances listed below. Select and use substances that do not cause any problems, and substances that do not alter or react with physiologically active substances. 1 Hardened vegetable fat or animal fat wax, such as beef tallow, rice wax, wood wax, beeswax, canadilla wax, carnauba wax, lanolin, etc.; 2 Straight chain or wax having 14 to 22 carbon atoms Branched saturated or unsaturated monocarboxylic acids; 3 Sucrose esters, glycerin fatty acid esters (di, tri, mono), propylene glycol fatty acid esters, sorbitan fatty acid esters, etc. The content of these protective substances in the coating layer is 25 to 98% by weight, preferably 35 to 75% by weight.
It is. If it is less than 25% by weight, specific amino acids and the like will not be sufficiently attached to the coating layer, resulting in poor durability in the rumen. Moreover, if it is 98% by weight or more, the content of components (specific amino acids, inorganic substances) that control dissolution from the abomasum onwards is too small to be expected to be effective. Hydrophobic Amino Acids Amino acids inherently have the lowest solubility in water at their isoelectric point (near PH 6) and increase in solubility in acidic or alkaline regions. Therefore, it has the property of being difficult to dissolve in the neutral range of rumen conditions and easy to dissolve in the acidic range of abomasum conditions, but if left as is, it will be decomposed in the rumen. The present inventors investigated the hydrophobic isoleucine (Ile), leucine (Leu), tryptophan (Trp), phenylalanine (Phe), and methionine (Met) among the amino acids that make up the proteins of living organisms that do not cause problems in feeding. , tyrosine (Tyr), asparagine (Asn), glutamine (Gln), cysteine (Cys), cystine (Cys−
We found that when Cys) or histidine (His) coexists with the above-mentioned protective substances, they are not decomposed in the rumen, but are reliably dissolved in the abomasum and beyond, making them suitable as a coating layer for ruminant granules. . All of the above hydrophobic amino acids are preferred, but
Particularly preferred are methionine, tyrosine, leucine, cysteine, and cystine. The above-mentioned hydrophobic amino acids are used alone or in a mixture of two or more at a content of 2 to 50% by weight, preferably 10 to 20% by weight in the coating layer. If it is less than 2% by weight, there is a problem in dissolution from the abomasum onwards.
Moreover, if it exceeds 50% by weight, durability in the rumen becomes insufficient. In addition to protective substances and amino acids, the inorganic coating layer may optionally contain substances that are stable under neutral (PH = 6 to 8) conditions in the rumen, but under acidic (PH = 3) conditions in the abomasum and beyond.
An inorganic substance that disintegrates or elutes under the following conditions may be used as desired. Examples of the inorganic substance include one or a mixture of two or more of magnesium oxide, magnesium hydroxide, magnesium carbonate, calcium oxide, calcium carbonate, calcium hydrogen phosphate, calcium phosphate, and calcium pyrophosphate, preferably magnesium oxide or a mixture containing magnesium oxide. is used. The content of inorganic substances in the coating layer is 0 to 70% by weight,
Preferably it is 30 to 50% by weight. Coating method In the present invention, the coating of the feed additive granules for ruminants is carried out by coating core particles containing a physiologically active substance as a main component with an amino acid and, if desired, an inorganic substance using oil as a binder. It is done by twisting. For example, above the melting point of fats and oils, preferably melting point +5
Using a granulator kept at a temperature above ℃, oil is added in powder form to the core particles, or oil is added in a pre-melted state, preferably by spraying, while at the same time finely powdered amino acids and, if desired, inorganic substances are added. This is done by adding. The thickness of the coating layer depends on the content of amino acids and inorganic substances in the coating layer, but it is usually sufficient to have a thickness of about 30 μm or more so that the surface of the core particles is completely covered. Effects of the Invention The feed additive granules for ruminants of the present invention consist of a core particle containing a physiologically active substance as a main component, a hydrophobic amino acid, a protective substance, and optionally an inorganic substance that is insoluble in a neutral region and soluble in an acidic region. It is difficult to dissolve in the rumen, but reliably dissolves in the abomasum and beyond, making it possible to effectively administer physiologically active substances to ruminants. Examples The present invention will be described below with reference to Examples and Comparative Examples. Example 1 1500 g of methionine, 500 g of tricalcium phosphate [Ca 3 (PO 4 ) 2 ], and 400 g of beef tallow were placed in a stirrer-type granulator, and the product temperature was brought to 70°C using a jacket of warm water.
Granulation was carried out for 25 minutes. Put 700g of 12-32 meshes of the obtained particles into a coater and add methionine (7μ).
A mixture of 35 g and 70 g of magnesium oxide was coated with 105 g of hot melted beef tallow to obtain granules of the present invention. The granules were placed in a nylon bag and immersed in the rumen of a cow fitted with rumen fistula for 24 hours, then taken out and analyzed for residual methionine to measure rumen dissolution. In addition, the residual rate of methionine in cow feces collected for 96 hours after oral administration of the granules was analyzed, and the residual rate after the rumen was measured. As a result, the rumen dissolution rate was 9.4.
%, and the persistence after the rumen was 0%. Example 2 Put 1700g of lysine and 810g of beef tallow into a granulator, and check the product temperature.
Granulation was carried out at 70°C for 40 minutes. 12 ~ of the resulting particles
700 g of 32 mesh was placed in a coater, and 30 g of tyrosine (20μ) was coated with 140 g of hot melted beef tallow to obtain granules. When this granule was subjected to the same test as in Example 1, the rumen dissolution was
The persistence after 20.2% rumen was 0%. Comparative Examples 1 to 3 Granules without coating in Example 1 (Comparative Example 1), Granules without coating in Example 2 (Comparative Example 2), and Example 1
In Example 1, granules coated only with beef tallow (Comparative Example 3) were prepared.
A similar test was conducted and the results shown in the table below were obtained.
【表】
実施例 3
塩化コリン1400g、炭酸カルシウム900g、牛脂
400gを造粒機に入れ、品温を70℃として40分間
造粒した。得られた粒子の12〜32メツシユ900g
をコーターに入れ、ロイシン(10μ)90g、炭酸
マグネシウム90gを混合したものを熱溶融した牛
脂175gでコーテイングし、粒剤を調製した。
この粒剤について実施例1と同様のテストを行
ない、第1胃溶出性33.3%、第1胃以降残存性
0%の結果を得た。
実施例 4
メチオニン1500g、炭酸カルシウム500gにセル
ロース繊維(商品名 KCフロツクW−100;山陽
国策パルプ社製)50g、牛脂400gを攪拌型造粒機
で70℃で造粒した。得られた粒子を篩分し、12〜
32メツシユのもの1000gをコータに入れ、グルタ
ミン(7μ)50gと水酸化マグネシウム100gを混合
したものを熱溶融した牛脂150gで55℃にてコー
テイングした。得られたグルタミン被覆メチオニ
ン粒剤の第1胃溶解性は下記のように12.4%と低
く耐久性があり、第4胃では完全に溶出した。
第1胃溶出性(24時間浸漬) 12.4%
第4胃以降残存制 0%
実施例 5
塩化コリン1400g、酸化マグネシウム400g、タ
ルク400g、牛脂400gを攪拌型造粒機を用いて70
℃で造粒した。得られた粒子の内8〜20メツシユ
のもの1000gをコーターに入れ、トリプトフアン
(15μ)75gと酸化マグネシウム75gを混合したも
のを熱溶融した牛脂150gでコーテイングした。
コリン粒剤をトリプトフアンを用いてコーテイン
グした本粒剤は下記のように第1胃の溶解性が20
%と低く良好であり、しかも第4胃で完全に溶解
した。
第1胃溶出性(24時間浸漬) 20.0%
第4胃以降残存性 0%
実施例 6
スレオニン1500g、炭酸カルシウム500g、セル
ロース繊維50g、牛脂400gを70℃で溶融法で攪拌
造粒した。得られた粒子の内8〜20メツシユのも
の1000gをコーターに入れ、フエニルアラニン
(10μ)50gと酸化マグネシウム50gと第2リン酸
カルシウム50gを混合したものを熱溶融した牛脂
150gでコーテイングした。得られたフエニルア
ラニンでコートしたスレオニン粒剤の性能は下記
のように、第1胃溶出性が11%とかなり耐久性が
あり、また第4胃以降では7.8%の残存率であつ
た。
第1胃溶出性(24時間浸漬) 11.0%
第4胃以降残存性 7.8%[Table] Example 3 Choline chloride 1400g, calcium carbonate 900g, beef tallow
400g was placed in a granulator and granulated for 40 minutes at a temperature of 70°C. 12-32 meshes 900g of the resulting particles
was placed in a coater, and a mixture of 90 g of leucine (10μ) and 90 g of magnesium carbonate was coated with 175 g of hot melted beef tallow to prepare granules. This granule was subjected to the same test as in Example 1, and the rumen dissolution rate was 33.3%, and the rumen persistence was 0%. Example 4 1500 g of methionine, 500 g of calcium carbonate, 50 g of cellulose fiber (trade name KC Flock W-100; manufactured by Sanyo Kokusaku Pulp Co., Ltd.), and 400 g of beef tallow were granulated at 70° C. using an agitating granulator. The obtained particles are sieved and 12~
1000 g of 32 mesh was placed in a coater and coated at 55°C with 150 g of hot melted beef tallow containing 50 g of glutamine (7 μ) and 100 g of magnesium hydroxide. The rumen solubility of the obtained glutamine-coated methionine granules was as low as 12.4%, as shown below, and was durable, and completely dissolved in the abomasum. Rumen dissolution (24 hour immersion) 12.4% Residue after the abomasum 0% Example 5 1400 g of choline chloride, 400 g of magnesium oxide, 400 g of talc, and 400 g of beef tallow were mixed using a stirrer-type granulator.
Granulation was carried out at ℃. Of the obtained particles, 1000 g of 8 to 20 meshes were placed in a coater, and a mixture of 75 g of tryptophan (15μ) and 75 g of magnesium oxide was coated with 150 g of hot melted beef tallow.
This granule, which is a choline granule coated with tryptophan, has a ruminal solubility of 20% as shown below.
%, which was good and was completely dissolved in the abomasum. Rumen dissolution (24-hour immersion) 20.0% Persistence after the abomasum 0% Example 6 1500 g of threonine, 500 g of calcium carbonate, 50 g of cellulose fiber, and 400 g of beef tallow were stirred and granulated at 70°C by a melting method. Put 1000g of the obtained particles of 8 to 20 mesh into a coater, and heat-melt beef tallow with a mixture of 50g of phenylalanine (10μ), 50g of magnesium oxide, and 50g of dibasic calcium phosphate.
Coated with 150g. The performance of the obtained threonine granules coated with phenylalanine was as shown below, and the rumen dissolution rate was 11%, which was quite durable, and the survival rate after the abomasum was 7.8%. Rumen dissolution (24 hour immersion) 11.0% Persistence beyond the abomasum 7.8%
Claims (1)
水性アミノ酸の1種または2種以上の混合物2〜
50重量%および保護物質25〜98重量%を含有する
コート層で被覆してなることを特徴とする反すう
動物用飼料添加物粒剤。 2 疎水性アミノ酸が、イソロイシン、ロイシ
ン、トリプトフアン、フエニルアラニン、メチオ
ニン、チロシン、アスパラギン、グルタミン、シ
ステイン、シスチン、またはヒスチジンである特
許請求の範囲第1項に記載の反すう動物用飼料添
加物粒剤。[Claims] 1. A core particle containing a physiologically active substance as a main component, 2.
A feed additive granule for ruminants, characterized in that it is coated with a coating layer containing 50% by weight and 25 to 98% by weight of a protective substance. 2. The ruminant feed additive granules according to claim 1, wherein the hydrophobic amino acid is isoleucine, leucine, tryptophan, phenylalanine, methionine, tyrosine, asparagine, glutamine, cysteine, cystine, or histidine. .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62167781A JPS6413953A (en) | 1987-07-07 | 1987-07-07 | Feed additive for ruminant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62167781A JPS6413953A (en) | 1987-07-07 | 1987-07-07 | Feed additive for ruminant |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6413953A JPS6413953A (en) | 1989-01-18 |
JPH0521B2 true JPH0521B2 (en) | 1993-01-05 |
Family
ID=15855991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62167781A Granted JPS6413953A (en) | 1987-07-07 | 1987-07-07 | Feed additive for ruminant |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6413953A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9757789B2 (en) | 2011-09-30 | 2017-09-12 | Nisshin Steel Co., Ltd. | Method of manufacturing rectangular tube having stepped portion |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0696023B2 (en) * | 1986-11-10 | 1994-11-30 | 宇部日東化成株式会社 | Artificial blood vessel and method for producing the same |
JP7363641B2 (en) * | 2020-03-31 | 2023-10-18 | 日油株式会社 | Feed composition |
-
1987
- 1987-07-07 JP JP62167781A patent/JPS6413953A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9757789B2 (en) | 2011-09-30 | 2017-09-12 | Nisshin Steel Co., Ltd. | Method of manufacturing rectangular tube having stepped portion |
Also Published As
Publication number | Publication date |
---|---|
JPS6413953A (en) | 1989-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4713245A (en) | Granule containing physiologically-active substance, method for preparing same and use thereof | |
US3655864A (en) | Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption | |
GB2121268A (en) | Feed additive for ruminants | |
WO2005104868A1 (en) | Feed additive composition for ruminant, feed containing the same and process for producing feed additive composition for ruminant | |
JPH09172979A (en) | Feed additive for ruminant containing new compound salt of phosphoric acid and amino acid and antacid | |
EP3405042B1 (en) | Compositions for improving nitrogen utilization in a ruminant | |
Beever et al. | The use of monensin or formaldehyde to control the digestion of the nitrogenous constituents of perennial ryegrass (Lolium perenne cv. Melle) and white clover (Trifolium repens cv. Blanca) in the rumen of cattle | |
JPH0720423B2 (en) | Feed additives for ruminants | |
GB2153199A (en) | Feed additive composition | |
JP3728738B1 (en) | Rumen bypass for ruminants | |
JPS6137054A (en) | Particle for feed additive | |
JP2929812B2 (en) | Ruminant feed additive composition | |
JPH0521B2 (en) | ||
JPH0424977B2 (en) | ||
JPH02295438A (en) | Feed pellet for milk secretion and and method for using the same | |
JPH0545221B2 (en) | ||
JPS61195653A (en) | Particle for ruminant | |
JPH0256063B2 (en) | ||
JP3266608B2 (en) | Ruminant feed additives | |
JPH02163043A (en) | Feed additive for ruminant | |
JPS60168350A (en) | Feed additive passing through rumen of ruminant | |
JP2533352B2 (en) | Feed additives for ruminants | |
JP2645497B2 (en) | Ruminant feed additives | |
JPH0829052B2 (en) | Feed additives for ruminants | |
JPH0683640B2 (en) | Feed additive composition for ruminants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |